Catherine Hutchings, PhDIndependent Consultant at Independent Consultant
Catherine has over 20 years experience in antibody drug discovery and platform applications, working for cutting edge biotech and pharma companies, including CAT (now MedImmune). She has worked with Heptares Therapeutics Ltd since 2008 attaining proof-of-concept studies and leading efforts in GPCR antibody discovery. In 2015, Catherine reverted to providing independent scientific and strategic consultancy services to biotechnology companies where her current assignments include GPCRs, ion channels, platform positioning and target evaluation. Catherine graduated with BSc Hons in Genetics and Cell Biology from University of Manchester, UK, and a PhD in Biochemistry and Applied Molecular Biology from UMIST, UK.